Wei Wei

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Metastatic Colorectal Cancer

Top Venues

Cancer research communications

Statistics in medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Statistical methods in medical research

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Wei, Ondrej Blaha, Denise A Esserman, Daniel Zelterman, Michael J Kane, Rachael Liu, Jianchang Lin
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in medicine 43 (12) (2024)
Wei Wei, Yunxuan Zhang, Satrajit Roychoudhury, null null
Propensity score weighted multi-source exchangeability models for incorporating external control data in randomized clinical trials. Statistics in medicine 43 (20) (2024)
Wei Wei, Ondrej Blaha, Denise A Esserman, Daniel Zelterman, Michael J Kane, Rachael Liu, Jianchang Lin
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in medicine (2024)
Wei Wei, Ondrej Blaha, Denise A Esserman, Daniel Zelterman, Michael J Kane, Rachael Liu, Jianchang Lin
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in medicine 43 (12) (2024)
Wei Wei, Ondrej Blaha, Denise A Esserman, Daniel Zelterman, Michael J Kane, Rachael Liu, Jianchang Lin
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in medicine 43 (12) (2024)
Wei Wei, Yunxuan Zhang, Satrajit Roychoudhury, null null
Propensity score weighted multi-source exchangeability models for incorporating external control data in randomized clinical trials. Statistics in medicine (2024)
Sarah A Weiss, Mario Sznol, Montaser Shaheen, Miguel-Angel Berciano-Guerrero, Eva Muñoz Couselo, Delvys Rodriguez Abreu, Valentina Boni, Lynn M Schuchter, Maria Gonzales Cao, Ana M Arance, Wei Wei, Apar Kishor Ganti, Ralph J Hauke, Alfonso Berrocal, Nicholas O Iannotti, Frank J Hsu, Harriet M Kluger
A Phase II Trial of the CD40 Agonist Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Disease Progression on Anti-PD-1. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Brooke Horowitch, Daniel Y Lee, Min Ding, Sandra Martinez-Morilla, Thazin Nwe Aung, Feriel Ouerghi, Xueting Wang, Wei Wei, William E Damsky, Mario Sznol, Harriet M Kluger, David L Rimm, Jeffrey Ishizuka
Subsets of interferon signaling predict response to immune checkpoint blockade in melanoma patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Michael Cecchini, Zenta Walther, Wei Wei, Navid Hafez, Mary Jo Pilat, Scott A Boerner, Diane E Durecki, Joseph Paul Eder, Kurt A Schalper, Helen X Chen, Patricia M LoRusso
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors. Cancer research communications 3 (6) (2023)
Michael Cecchini, Zenta Walther, Wei Wei, Navid Hafez, Mary Jo Pilat, Scott A Boerner, Diane E Durecki, Joseph Paul Eder, Kurt A Schalper, Helen X Chen, Patricia M LoRusso
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors. Cancer research communications 3 (6) (2023)
Michael Cecchini, Zenta Walther, Wei Wei, Navid Hafez, Mary Jo Pilat, Scott A Boerner, Diane E Durecki, Joseph Paul Eder, Kurt A Schalper, Helen X Chen, Patricia M LoRusso
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors. Cancer research communications 3 (6) (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Michael Cecchini, Zenta Walther, Wei Wei, Navid Hafez, Mary Jo Pilat, Scott A Boerner, Diane E Durecki, Joseph Paul Eder, Kurt A Schalper, Helen X Chen, Patricia M LoRusso
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors. Cancer research communications 3 (6) (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Michael Cecchini, Zenta Walther, Wei Wei, Navid Hafez, Mary Jo Pilat, Scott A Boerner, Diane E Durecki, Joseph Paul Eder, Kurt A Schalper, Helen X Chen, Patricia M LoRusso
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors. Cancer research communications 3 (6) (2023)
Yilin Liu, Michael Kane, Denise A Esserman, Ondrej Blaha, Daniel Zelterman, Wei Wei
Bayesian local exchangeability design for phase II basket trials. Statistics in medicine 41 (22) (2022)
Wei Wei, Denise A Esserman, Michael Kane, Daniel Zelterman
Unified exact design with early stopping rules for single arm clinical trials with multiple endpoints. Statistical methods in medical research 30 (7) (2021)